What is Genosource?
Established in 2014 by a collective of dairymen, GenoSource has emerged as a premier provider of high genetic caliber cattle, embryos, and sires, with a pronounced focus on the dairy industry. The company leverages advanced breeding and embryo programs to develop cows that are both efficient and profitable. Operating with a substantial milking herd of 4,000 cows, GenoSource is committed to delivering modern genetics at competitive price points, thereby addressing the dynamic requirements of dairymen and fostering a sustainable, lucrative future for the dairy sector.
How much funding has Genosource raised?
Genosource has raised a total of $775K across 2 funding rounds:
Debt
$350K
Debt
$425K
Debt (2020): $350K with participation from PPP
Debt (2021): $425K led by PPP
What's next for Genosource?
The recent major strategic investment signals a new phase of growth and development for Genosource. This capital infusion is expected to accelerate the company's initiatives in genetic advancement and potentially expand its operational footprint. The enterprise-level funding context suggests a strategic focus on scaling operations, enhancing research and development in breeding technologies, and solidifying its market position as a leader in dairy genetics. Future endeavors will likely concentrate on further optimizing cow profitability and efficiency through cutting-edge genetic solutions.
See full Genosource company page
